Simply Wall St.
Is InnovAge Holding (INNV) Still Attractive After Its 145% One Year Share Price Rebound?
📈
AI Sentiment
Highly Positive
8/10
- Home
- INNV
as of 03-20-2026 3:38pm EST
$7.72
$0.64
-7.66%
InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | DENVER |
| Market Cap: | 1.2B | IPO Year: | 2021 |
| Target Price: | $7.00 | AVG Volume (30 days): | 337.0K |
| Analyst Decision: | Sell | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.14 | EPS Growth: | -37.50 |
| 52 Week Low/High: | $2.60 - $10.69 | Next Earning Date: | 05-05-2026 |
| Revenue: | $853,699,000 | Revenue Growth: | 11.76% |
| Revenue Growth (this year): | 12.85% | Revenue Growth (next year): | 8.88% |
| P/E Ratio: | 59.68 | Index: | N/A |
| Free Cash Flow: | 26.6M | FCF Growth: | N/A |
AI-Powered INNV Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 3 days ago
AI Recommendation
hold
Model Accuracy: 70.44%
70.44%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K BUY Feb 3, 2026 · 100% conf.
2025
Q4
Q4 2025 Earnings
8-K BUYFeb 3, 2026 · 100% conf.
AI Prediction BUY
1D
+1.21%
$5.73
Act: +37.46%
5D
+19.57%
$6.77
Act: +47.88%
20D
+12.27%
$6.35
Act: +88.16%
Price: $5.66 Prob +5D: 100% AUC: 1.000
0001834376-26-000012
innv-20260203FALSE000183437600018343762026-02-032026-02-03
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 3, 2026
INNOVAGE HOLDING CORP.
(Exact name of registrant as specified in its charter)
Delaware001-4015981-0710819 (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)
8950 E. Lowry Boulevard Denver, CO 80230 (Address of principal executive offices)(Zip Code)
(844) 803-8745 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s)Name of each exchange on which registered Common Stock, $0.001 par value INNVThe Nasdaq Stock Market LLC (Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company x If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Item 2.02. Results of Operations and Financial Condition. On February 3, 2026, InnovAge Holding Corp. issued a press release announcing financial results for the second fiscal quarter ended December 31, 2025, and related matters. A copy of this press release is furnished as Exhibit 99.1 hereto and is incorporated in this Item 2.02 by reference. The information in this Item 2.02, including the exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. This information shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference to such disclosure in this Form 8-K in such a filing.
Item 9.01. Financial Statements and Exhibits. (d) Exhibits
ExhibitDescription
99.1Press Release of InnovAge Holding Corp., dated February 3, 2026
104Cover Page Interactive Data File (formatted as Inline XBRL)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
INNOVAGE HOLDING CORP.
Date: February 3, 2026 By:/s/ Benjamin C. Adams
Name: Benjamin C. Adams Title: Chief Financial Officer
2025 Q3 Q3 2025 Earnings
8-K Nov 4, 2025
2025
Q3
Q3 2025 Earnings
8-KNov 4, 2025
0001834376-25-000072
innv-20251104FALSE000183437600018343762025-11-042025-11-04
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2025
INNOVAGE HOLDING CORP.
(Exact name of registrant as specified in its charter)
Delaware001-4015981-0710819 (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)
8950 E. Lowry Boulevard Denver, CO 80230 (Address of principal executive offices)(Zip Code)
(844) 803-8745 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s)Name of each exchange on which registered Common Stock, $0.001 par value INNVThe Nasdaq Stock Market LLC (Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company x If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Item 2.02. Results of Operations and Financial Condition. On November 4, 2025, InnovAge Holding Corp. issued a press release announcing financial results for the first fiscal quarter ended September 30, 2025, and related matters. A copy of this press release is furnished as Exhibit 99.1 hereto and is incorporated in this Item 2.02 by reference. The information in this Item 2.02, including the exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. This information shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference to such disclosure in this Form 8-K in such a filing.
Item 9.01. Financial Statements and Exhibits. (d) Exhibits
ExhibitDescription
99.1Press Release of InnovAge Holding Corp., dated November 4, 2025
104Cover Page Interactive Data File (formatted as Inline XBRL)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
INNOVAGE HOLDING CORP.
Date: November 4, 2025 By:/s/ Benjamin C. Adams
Name: Benjamin C. Adams Title: Chief Financial Officer
2025 Q2 Q2 2025 Earnings
8-K Sep 9, 2025
2025
Q2
Q2 2025 Earnings
8-KSep 9, 2025
0001834376-25-000060
innv-20250909FALSE000183437600018343762025-09-092025-09-09
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 9, 2025
INNOVAGE HOLDING CORP.
(Exact name of registrant as specified in its charter)
Delaware001-4015981-0710819 (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)
8950 E. Lowry Boulevard Denver, CO 80230 (Address of principal executive offices)(Zip Code)
(844) 803-8745 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s)Name of each exchange on which registered Common Stock, $0.001 par value INNVThe Nasdaq Stock Market LLC (Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company x If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Item 2.02. Results of Operations and Financial Condition. On September 9, 2025, InnovAge Holding Corp. issued a press release announcing financial results for the fiscal fourth quarter and full year ended June 30, 2025, and related matters. A copy of this press release is furnished as Exhibit 99.1 hereto and is incorporated in this Item 2.02 by reference. The information in this Item 2.02, including the exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. This information shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference to such disclosure in this Form 8-K in such a filing.
Item 9.01. Financial Statements and Exhibits. (d) Exhibits
ExhibitDescription
99.1Press Release of InnovAge Holding Corp., dated September 9, 2025
104Cover Page Interactive Data File (formatted as Inline XBRL)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
INNOVAGE HOLDING CORP.
Date: September 9, 2025 By:/s/ Benjamin C. Adams
Name: Benjamin C. Adams
Title: Chief Financial Officer
Latest InnovAge Holding Corp. News
INNV Breaking Stock News: Dive into INNV Ticker-Specific Updates for Smart Investing
Compare INNV vs Leading Stocks
See how INNV stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "INNV InnovAge Holding Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.